Healthcare provider profile · identity verified

Miguel Posada, APRN

Nurse Practitioner · SPOKANE, WA · NPI 1992320949

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	318	86
Lisinopril	Lisinopril	186	47
Gabapentin	Gabapentin	142	33
Amlodipine Besylate	Amlodipine Besylate	134	39
Losartan Potassium	Losartan Potassium	102	33
Metoprolol Succinate	Metoprolol Succinate	95	27
Levothyroxine Sodium	Levothyroxine Sodium	90	27
Trazodone Hcl	Trazodone Hcl	85	21
Metformin Hcl Er	Metformin Hcl	82	27
Bupropion Xl	Bupropion Hcl	81	18
Escitalopram Oxalate	Escitalopram Oxalate	75	16
Sertraline Hcl	Sertraline Hcl	72	18
Tamsulosin Hcl	Tamsulosin Hcl	70	20
Metformin Hcl	Metformin Hcl	63	16
Jardiance	Empagliflozin	60	15
Albuterol Sulfate Hfa	Albuterol Sulfate	59	28
Eliquis	Apixaban	55	16
Omeprazole	Omeprazole	54	23
Metoprolol Tartrate	Metoprolol Tartrate	51	suppressed
Duloxetine Hcl	Duloxetine Hcl	49	14
Pantoprazole Sodium	Pantoprazole Sodium	44	suppressed
Spiriva Handihaler	Tiotropium Bromide	43	11
Hydroxyzine Hcl	Hydroxyzine Hcl	41	19
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	39	suppressed
Paroxetine Hcl	Paroxetine Hcl	39	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	39	14
Buspirone Hcl	Buspirone Hcl	37	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	37	14
Famotidine	Famotidine	34	11
Fluticasone Propionate	Fluticasone Propionate	30	12
Ozempic	Semaglutide	29	12
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	26	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	26	21
Januvia	Sitagliptin Phosphate	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	11
Lorazepam	Lorazepam	23	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	22	21
Furosemide	Furosemide	22	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Allopurinol	Allopurinol	19	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Divalproex Sodium Er	Divalproex Sodium	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Baclofen	Baclofen	16	suppressed
Carvedilol	Carvedilol	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Potassium Chloride	Potassium Chloride	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	14	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Ammonium Lactate	Ammonium Lactate	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error